Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
976 | 2926 | 29.8 | 81% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
21 | 4 | UROLOGY & NEPHROLOGY//UROL//JOURNAL OF UROLOGY | 229838 |
272 | 3 | PROSTATE CANCER//PROSTATIC NEOPLASMS//UROL | 43768 |
74 | 2 | PROSTATE CANCER//PROSTATIC NEOPLASMS//RADICAL PROSTATECTOMY | 27992 |
976 | 1 | PROSTATE SPECIFIC ANTIGEN//FREE PSA//PSA | 2926 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | PROSTATE SPECIFIC ANTIGEN | authKW | 2352180 | 31% | 25% | 901 |
2 | FREE PSA | authKW | 841059 | 3% | 88% | 92 |
3 | PSA | authKW | 448715 | 9% | 16% | 271 |
4 | FREE PROSTATE SPECIFIC ANTIGEN | authKW | 357099 | 1% | 93% | 37 |
5 | PROPSA | authKW | 231150 | 1% | 92% | 24 |
6 | PROSTATE CANCER | authKW | 191727 | 24% | 3% | 701 |
7 | PROSTATIC NEOPLASMS | authKW | 189262 | 10% | 6% | 300 |
8 | COMPLEXED PSA | authKW | 188332 | 1% | 95% | 19 |
9 | DIGITAL RECTAL EXAMINATION | authKW | 187976 | 2% | 32% | 56 |
10 | PERCENT FREE PSA | authKW | 171208 | 1% | 86% | 19 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Urology & Nephrology | 89032 | 51% | 1% | 1482 |
2 | Medical Laboratory Technology | 11781 | 11% | 0% | 313 |
3 | Oncology | 3330 | 19% | 0% | 556 |
4 | Andrology | 973 | 1% | 0% | 35 |
5 | Medicine, General & Internal | 634 | 8% | 0% | 246 |
6 | Endocrinology & Metabolism | 263 | 5% | 0% | 144 |
7 | Pathology | 93 | 2% | 0% | 68 |
8 | Primary Health Care | 43 | 0% | 0% | 14 |
9 | Medicine, Research & Experimental | 28 | 2% | 0% | 71 |
10 | BIOLOGY, MISCELLANEOUS | 23 | 0% | 0% | 2 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | UROL | 94138 | 34% | 1% | 996 |
2 | BUSINESS GRP DIAGNOST | 57376 | 0% | 50% | 11 |
3 | NW PROSTATE | 44511 | 0% | 53% | 8 |
4 | NAZL PLICAZ BIOTECNOL ONCOL | 31302 | 0% | 100% | 3 |
5 | PROSTAT PATHOL UNIT | 28979 | 0% | 56% | 5 |
6 | UNIV HOSP UMAS | 26070 | 0% | 25% | 10 |
7 | SOUTH BEDFORDSHIRE HERTFORDSHIRE UROL CANC | 23846 | 0% | 57% | 4 |
8 | HORMONAL BIOREGULAT | 23708 | 0% | 45% | 5 |
9 | BIOCHEM MOL GENET CDB | 21732 | 0% | 42% | 5 |
10 | BRIGHAM WOMENS HOSP MED UROL SURG | 20868 | 0% | 100% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | UROLOGY | 67724 | 11% | 2% | 325 |
2 | JOURNAL OF UROLOGY | 34096 | 10% | 1% | 302 |
3 | EUROPEAN UROLOGY | 27864 | 5% | 2% | 139 |
4 | PROSTATE | 27674 | 4% | 2% | 110 |
5 | PROSTATE CANCER AND PROSTATIC DISEASES | 16207 | 1% | 4% | 41 |
6 | CLINICAL CHEMISTRY | 12190 | 4% | 1% | 118 |
7 | UROLOGIC CLINICS OF NORTH AMERICA | 10739 | 2% | 2% | 50 |
8 | BJU INTERNATIONAL | 8106 | 3% | 1% | 80 |
9 | BRITISH JOURNAL OF UROLOGY | 7016 | 2% | 1% | 64 |
10 | INTERNATIONAL JOURNAL OF UROLOGY | 6463 | 2% | 1% | 45 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PROSTATE SPECIFIC ANTIGEN | 2352180 | 31% | 25% | 901 | Search PROSTATE+SPECIFIC+ANTIGEN | Search PROSTATE+SPECIFIC+ANTIGEN |
2 | FREE PSA | 841059 | 3% | 88% | 92 | Search FREE+PSA | Search FREE+PSA |
3 | PSA | 448715 | 9% | 16% | 271 | Search PSA | Search PSA |
4 | FREE PROSTATE SPECIFIC ANTIGEN | 357099 | 1% | 93% | 37 | Search FREE+PROSTATE+SPECIFIC+ANTIGEN | Search FREE+PROSTATE+SPECIFIC+ANTIGEN |
5 | PROPSA | 231150 | 1% | 92% | 24 | Search PROPSA | Search PROPSA |
6 | PROSTATE CANCER | 191727 | 24% | 3% | 701 | Search PROSTATE+CANCER | Search PROSTATE+CANCER |
7 | PROSTATIC NEOPLASMS | 189262 | 10% | 6% | 300 | Search PROSTATIC+NEOPLASMS | Search PROSTATIC+NEOPLASMS |
8 | COMPLEXED PSA | 188332 | 1% | 95% | 19 | Search COMPLEXED+PSA | Search COMPLEXED+PSA |
9 | DIGITAL RECTAL EXAMINATION | 187976 | 2% | 32% | 56 | Search DIGITAL+RECTAL+EXAMINATION | Search DIGITAL+RECTAL+EXAMINATION |
10 | PERCENT FREE PSA | 171208 | 1% | 86% | 19 | Search PERCENT+FREE+PSA | Search PERCENT+FREE+PSA |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | RITTENHOUSE, HG , FINLAY, JA , MIKOLAJCZYK, SD , PARTIN, AW , (1998) HUMAN KALLIKREIN 2 (HK2) AND PROSTATE-SPECIFIC ANTIGEN (PSA): TWO CLOSELY RELATED, BUT DISTINCT, KALLIKREINS IN THE PROSTATE.CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES. VOL. 35. ISSUE 4. P. 275 -368 | 245 | 69% | 206 |
2 | PLACER, J , PIANOS, J , CELMA, A , MOROTE, J , (2015) CURRENT ROLE OF PROTATIC SPECIFIC ANTIGEN (PSA) AND ITS BY-PRODUCTS IN THE DIAGNOSIS OF PROSTATE CANCER.ARCHIVOS ESPANOLES DE UROLOGIA. VOL. 68. ISSUE 3. P. 210 -228 | 170 | 75% | 0 |
3 | BECKER, C , NOLDUS, J , DIAMANDIS, E , LILJA, H , (2001) THE ROLE OF MOLECULAR FORMS OF PROSTATE-SPECIFIC ANTIGEN (PSA OR HK3) AND OF HUMAN GLANDULAR KALLIKREIN 2 (HK2) IN THE DIAGNOSIS AND MONITORING OF PROSTATE CANCER AND IN EXTRA-PROSTATIC DISEASE.CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES. VOL. 38. ISSUE 5. P. 357 -399 | 200 | 82% | 16 |
4 | STEPHAN, C , JUNG, K , LEIN, M , SINHA, P , SCHNORR, D , LOENING, SA , (2000) MOLECULAR FORMS OF PROSTATE-SPECIFIC ANTIGEN AND HUMAN KALLIKREIN 2 AS PROMISING TOOLS FOR EARLY DIAGNOSIS OF PROSTATE CANCER.CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. VOL. 9. ISSUE 11. P. 1133-1147 | 171 | 90% | 60 |
5 | KARAZANASHVILI, G , ABRAHAMSSON, PA , (2003) PROSTATE SPECIFIC ANTIGEN AND HUMAN GLANDULAR KALLIKREIN 2 IN EARLY DETECTION OF PROSTATE CANCER.JOURNAL OF UROLOGY. VOL. 169. ISSUE 2. P. 445-457 | 116 | 94% | 18 |
6 | PRICE, CP , ALLARD, J , DAVIES, G , DAWNAY, A , DUFFY, MJ , FRANCE, M , MANDARINO, G , WARD, AM , PATEL, B , SIBLEY, P , ET AL (2001) PRE- AND POST-ANALYTICAL FACTORS THAT MAY INFLUENCE USE OF SERUM PROSTATE SPECIFIC ANTIGEN AND ITS ISOFORMS IN A SCREENING PROGRAMME FOR PROSTATE CANCER.ANNALS OF CLINICAL BIOCHEMISTRY. VOL. 38. ISSUE . P. 188 -216 | 118 | 91% | 29 |
7 | ALACREU, JMA , ROSALES, SN , ALBA, AB , FURIO, FE , MARTINEZ, FM , CRUZ, JFJ , (2008) PSA AND HK2 IN THE DIAGNOSIS OF PROSTATE CANCER.ACTAS UROLOGICAS ESPANOLAS. VOL. 32. ISSUE 6. P. 575 -588 | 92 | 93% | 2 |
8 | STEPHAN, C , JUNG, K , LEIN, M , DIAMANDIS, EP , (2007) PSA AND OTHER TISSUE KALLIKREINS FOR PROSTATE CANCER DETECTION.EUROPEAN JOURNAL OF CANCER. VOL. 43. ISSUE 13. P. 1918-1926 | 101 | 77% | 42 |
9 | HOFFMAN, RM , CLANON, DL , CHAVEZ, M , PEIRCE, JC , (2002) USING MULTIPLE CUTPOINTS FOR THE FREE-TO-TOTAL PROSTATE SPECIFIC ANTIGEN RATIO IMPROVES THE ACCURACY OF PROSTATE CANCER DETECTION.PROSTATE. VOL. 52. ISSUE 2. P. 150 -158 | 98 | 97% | 1 |
10 | WU, P , KOISTINEN, H , FINNE, P , ZHANG, WM , ZHU, L , LEINONEN, J , STENMAN, UH , (2006) ADVANCES IN PROSTATE-SPECIFIC ANTIGEN TESTING.ADVANCES IN CLINICAL CHEMISTRY, VOL 41. VOL. 41. ISSUE . P. 231 -261 | 122 | 68% | 2 |
Classes with closest relation at Level 1 |